RMC Pharmaceutical Solutions Revenue and Competitors

Boulder, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RMC Pharmaceutical Solutions's estimated annual revenue is currently $4M per year.(i)
  • RMC Pharmaceutical Solutions's estimated revenue per employee is $155,000

Employee Data

  • RMC Pharmaceutical Solutions has 26 Employees.(i)
  • RMC Pharmaceutical Solutions grew their employee count by -21% last year.

RMC Pharmaceutical Solutions's People

NameTitleEmail/Phone
1
President/CEO Reveal Email/Phone
2
Accountant/Office managerReveal Email/Phone
3
Quality Systems ManagerReveal Email/Phone
4
Business & Finance ManagerReveal Email/Phone
5
Sr. ConsultantReveal Email/Phone
6
Senior ConsultantReveal Email/Phone
7
Senior ConsultantReveal Email/Phone
8
Senior ConsultantReveal Email/Phone
9
founding memberReveal Email/Phone
10
Project Specialist | ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35483%$25MN/A
#2
$2M1318%N/AN/A
#3
$3.4M2210%N/AN/A
#4
$68M439-3%N/AN/A
#5
$2M1330%N/AN/A
#6
$4M268%N/AN/A
#7
$2.7M35-10%$23.2MN/A
#8
$5.3M3470%N/AN/A
#9
$1.7M11-8%N/AN/A
#10
$3.1M20-17%N/AN/A
Add Company

What Is RMC Pharmaceutical Solutions?

RMC Pharmaceutical Solutions Incorporated (RMC) is an expert technical services organization with a focus on solving CMC (Chemistry, Manufacturing and Control) issues in the bio/pharmaceutical industry. We support areas such as process, analytical and formulation development; quality control and quality assurance; GLP/GMP manufacturing of API and drug product; and packaging/distribution. Our team has the experience and talent to handle any product development project for a new therapeutic, diagnostic or device.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M2630%N/A
#2
$5.3M260%N/A
#3
$7.6M27-4%N/A
#4
$2.7M27N/AN/A
#5
$5.3M28-10%N/A